Baozhen Wang

4PUBLICATIONS
24CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 30, 2026
Targeting PKMYT1 enhances antitumor immune responses to PD-L1 blockade in castration-resistant prostate cancer.

Lin Gao, Baozhen Wang, Hui Liu

|Jan 30, 2026
FOSL2 Regulates PD-L1 and Modulates Hormone Therapy Response Heterogeneity.

Feifei Sun, Baozhen Wang, Shuyu Mei

Pageof 1